Critical Limb Ischemia Global Clinical Trials Review, H1, 2012

GlobalData, May 2012, Pages: 101

Critical Limb Ischemia Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Critical Limb Ischemia Global Clinical Trials Review, H1, 2012" provides data on the Critical Limb Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Critical Limb Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Critical Limb Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Critical Limb Ischemia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Critical Limb Ischemia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Critical Limb Ischemia
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Critical Limb Ischemia
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Critical Limb Ischemia Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Stempeutics Research Private Limited
Clinical Trial Overview of Stempeutics Research Private Limited
Pluristem Therapeutics Inc.
Clinical Trial Overview of Pluristem Therapeutics Inc.
Medistem, Inc.
Clinical Trial Overview of Medistem, Inc.
TCA Cellular Therapy, LLC
Clinical Trial Overview of TCA Cellular Therapy, LLC
Juventas Therapeutics, Inc.
Clinical Trial Overview of Juventas Therapeutics, Inc.
AnGes MG, Inc.
Clinical Trial Overview of AnGes MG, Inc.
ViroMed Co., Ltd.
Clinical Trial Overview of ViroMed Co., Ltd.
Aastrom Biosciences, Inc.
Clinical Trial Overview of Aastrom Biosciences, Inc.
Salus Pharmaceuticals Pvt. Ltd.
Clinical Trial Overview of Salus Pharmaceuticals Pvt. Ltd.
BI BIOTECH INDIA PRIVATE LIMITED
Clinical Trial Overview of BI BIOTECH INDIA PRIVATE LIMITED
Harvest Pharmaceuticals Inc
Clinical Trial Overview of Harvest Pharmaceuticals Inc
Bayer AG
Clinical Trial Overview of Bayer AG
HyperMed, Inc.
Clinical Trial Overview of HyperMed, Inc.
Aldagen, Inc.
Clinical Trial Overview of Aldagen, Inc.
MultiGene Vascular Systems (MGVS) Ltd.
Clinical Trial Overview of MultiGene Vascular Systems (MGVS) Ltd.
Sangart, Inc.
Clinical Trial Overview of Sangart, Inc.
W. L. Gore & Associates, Inc.
Clinical Trial Overview of W. L. Gore & Associates, Inc.
United Therapeutics Corporation
Clinical Trial Overview of United Therapeutics Corporation
Biotronik SE & Co. KG
Clinical Trial Overview of Biotronik SE & Co. KG
Covidien plc
Clinical Trial Overview of Covidien plc
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Flanders Medical Research Program
Clinical Trial Overview of Flanders Medical Research Program
Northwestern University
Clinical Trial Overview of Northwestern University
CHU de Reims
Clinical Trial Overview of CHU de Reims
Kansai Rosai Hospital
Clinical Trial Overview of Kansai Rosai Hospital
Institute of Biomedical Research and Innovation
Clinical Trial Overview of Institute of Biomedical Research and Innovation
Baylor Research Institute
Clinical Trial Overview of Baylor Research Institute
The Center of Nutrigenomics of the Technical University Munich
Clinical Trial Overview of The Center of Nutrigenomics of the Technical University Munich
Ochsner Health System
Clinical Trial Overview of Ochsner Health System
VIVA Physicians
Clinical Trial Overview of VIVA Physicians
University of Wisconsin Madison
Clinical Trial Overview of University of Wisconsin Madison
Royan Institute
Clinical Trial Overview of Royan Institute
Southern Arizona VA Health Care System
Clinical Trial Overview of Southern Arizona VA Health Care System
Chang Gung Memorial Hospital
Clinical Trial Overview of Chang Gung Memorial Hospital
Carmel Medical Center
Clinical Trial Overview of Carmel Medical Center
Hiroshima University Hospital
Clinical Trial Overview of Hiroshima University Hospital
IRCCS Policlinico San Matteo
Clinical Trial Overview of IRCCS Policlinico San Matteo
University Hospital Freiburg
Clinical Trial Overview of University Hospital Freiburg
University Hospital Tubingen
Clinical Trial Overview of University Hospital Tubingen
Kyoto University
Clinical Trial Overview of Kyoto University
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, BRIC Countries, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, G7 Countries, 2012-
Critical Limb Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, E7 Countries, 2012-
Critical Limb Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Critical Limb Ischemia Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stempeutics Research Private Limited, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medistem, Inc., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by TCA Cellular Therapy, LLC, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Juventas Therapeutics, Inc., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroMed Co., Ltd., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Salus Pharmaceuticals Pvt. Ltd., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by BI BIOTECH INDIA PRIVATE LIMITED, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Harvest Pharmaceuticals Inc, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by HyperMed, Inc., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aldagen, Inc., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by MultiGene Vascular Systems (MGVS) Ltd., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sangart, Inc., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by W. L. Gore & Associates, Inc., 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotronik SE & Co. KG, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Covidien plc, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Flanders Medical Research Program, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by CHU de Reims, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Rosai Hospital, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Biomedical Research and Innovation, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor Research Institute, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Center of Nutrigenomics of the Technical University Munich, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ochsner Health System, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by VIVA Physicians, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Royan Institute, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Southern Arizona VA Health Care System, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Hospital, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Carmel Medical Center, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico San Matteo, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Tubingen, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012-

List of Figures
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, G7 Countries (%), 2012-
Critical Limb Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, E7 Countries (%), 2012-
Critical Limb Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Cholangitis Global Clinical Trials Review, H1, 2013
• Anal Fissure Global Clinical Trials Review, H1, 2013
• Hemostasis Global Clinical Trials Review, H1, 2013
• Keratitis Global Clinical Trials Review, H2, 2012
• Bronchitis Global Clinical Trials Review, H2, 2012
• Strabismus Global Clinical Trials Review, H1, 2013
• Peptic Ulcers Global Clinical Trials Review, H2, 2012
• Otitis Media Global Clinical Trials Review, H2, 2012
• Osteoporosis Global Clinical Trials Review, H2, 2012
• Pruritus Global Clinical Trials Review, H2, 2012